Fortive Corp (FTV)

Fortive Corporation, headquartered in Everett, Washington, is a Delaware corporation incorporated in 2015 as part of its 2016 spin-off from Danaher Corporation and listed on the NYSE. The company develops, manufactures, and markets products, software, and services designed to keep the world safe and productive, employing more than 10,000 professionals across roughly 50 countries. On June 28, 2025, Fortive completed the tax-free spin-off of its Precision Technologies segment into an independent public company, Ralliant Corporation, and now operates in two segments: Intelligent Operating Solutions and Advanced Healthcare Solutions.

The Intelligent Operating Solutions segment provides advanced instrumentation, software, and services—including maintenance and repair tools, condition monitoring, facility and asset lifecycle software, and connected worker safety and compliance solutions—serving industries such as manufacturing, utilities, healthcare, and communications under brands including Fluke, ServiceChannel, Gordian, Accruent, Industrial Scientific, and Intelex. The Advanced Healthcare Solutions segment offers instrument sterilization, tracking, biomedical testing, radiation detection, and clinical productivity solutions under brands such as Advanced Sterilization Products (ASP), Censis, Fluke Biomedical, Landauer, and ProVation, helping healthcare providers meet safety standards and improve operational efficiency. The company’s operations are guided by the Fortive Business System (FBS), a continuous-improvement culture and operating framework incorporating AI and machine learning to drive growth, innovation, and disciplined capital allocation under its “Fortive Accelerated” strategy.

Fortive sources raw materials such as electronic components, steel, plastics, aluminum, and copper from a diversified global supplier base, and manages risks from tariffs, geopolitical tensions, and supply chain disruptions through strategies like safety stock and supplier diversification. The company holds numerous patents, trademarks, and trade secrets but considers no single asset material to its overall business. It faces broad competition across its diverse end markets, with no dominant single competitor, and considers itself a market leader in many served niches.

A portion of revenue derives from government contracts, subjecting Fortive to applicable procurement regulations. Given its healthcare-related offerings, the company is subject to extensive regulatory oversight, including U.S. FDA medical device regulations, EU MDR/UK UKCA requirements, and healthcare fraud and abuse laws such as the Anti-Kickback Statute, HIPAA, and the False Claims Act. Fortive also complies with anti-bribery laws (FCPA, UK Bribery Act), global data privacy regulations (GDPR, CCPA, LGPD, and others), environmental and workplace safety laws, and U.S. and international export/import and trade sanction regulations.

The company’s international operations span Europe, Asia, and other regions, providing geographic diversification, economies of scale, and access to new markets, with sales conducted through subsidiaries, direct channels, and distributors depending on the market. Fortive maintains its SEC filings and additional information through its corporate website.